Hongwu Li
Hefei, 230011, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Augmented ERO1α upon mTORC1 activation induces ferroptosis resistance and tumor progression via upregulation of SLC7A11.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 01, 2024
STAT3/miR-130b-3p/MBNL1 feedback loop regulated by mTORC1 signaling promotes angiogenesis and tumor growth.
Journal: Journal of experimental & clinical cancer research : CR
Published: August 15, 2022
Pescadillo ribosomal biogenesis factor 1 reduction suppresses tumour growth and renders chemosensitivity of head and neck squamous cell carcinoma.
Journal: Cancer medicine
Published: July 20, 2022
Circular RNA coiled-coil domain containing 66 regulates malignant development of papillary thyroid carcinoma by upregulating La ribonucleoprotein 1 via the sponge effect on miR-129-5p.
Journal: Bioengineered
Published: March 10, 2022
RUNX1/EGFR pathway contributes to STAT3 activation and tumor growth caused by hyperactivated mTORC1.
RUNX1/EGFR pathway contributes to STAT3 activation and tumor growth caused by hyperactivated mTORC1.
Journal: Molecular therapy oncolytics
Published: April 18, 2021
MicroRNA-144: A novel biological marker and potential therapeutic target in human solid cancers.
Journal: Journal of Cancer
Published: March 24, 2020
Upregulation of 6-phosphofructo-2-kinase (PFKFB3) by hyperactivated mammalian target of rapamycin complex 1 is critical for tumor growth in tuberous sclerosis complex.
Journal: IUBMB life
Published: October 27, 2019
mTORC1-mediated downregulation of COX2 restrains tumor growth caused by TSC2 deficiency.
Journal: Oncotarget
Published: January 16, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026